サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1066919

世界および米国のCRM197市場と予測（2022年～2028年）

Global and United States CRM197 Market Report & Forecast 2022-2028
出版日: | 発行: QYResearch | ページ情報: 英文 75 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
世界および米国のCRM197市場と予測（2022年～2028年）
出版日: 2022年03月26日
発行: QYResearch
ページ情報: 英文 75 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のCRM197の市場規模は、2022年の1億7,706万米ドルから、レビュー期間中に5.26％のCAGRで推移し、2028年までに2億4,083万米ドルに達すると予測されています。

また、米国の市場規模は、2021年の1億2,412万米ドルから、予測期間中に5.58％のCAGRで推移し、2028年には1億7,523万米ドルに達すると予測されています。

当レポートでは、世界および米国のCRM197市場について調査し、市場規模や予測、タイプ・用途・企業・地域別の市場分析、市場力学、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 調査範囲

  • CRM197製品イントロダクション
  • 世界のCRM197の見通し（2017 VS 2022 VS 2028）
    • 世界のCRM197市場規模（2017-2028）
    • 米国のCRM197市場規模（2017-2028）
  • 米国と世界の市場規模比較（2017 VS 2022 VS 2028）
    • 世界のでの米国CRM197の市場規模
    • 米国と世界の市場規模成長率の比較
  • CRM197の市場力学
    • 業界の動向
    • 市場の促進要因
    • 市場の課題
    • 市場の抑制要因
  • 調査目的
  • 考察年

第2章 タイプ別：CRM197

  • タイプ別：CRM197市場セグメント
    • 研究グレード
    • CGMPグレード
  • タイプ別：世界のCRM197市場規模（2017、2022、2028）
  • タイプ別：世界のCRM197市場規模（2017-2028）
  • タイプ別：米国のCRM197市場規模（2017、2022、2028）
  • タイプ別：米国のCRM197市場規模（2017-2028）

第3章 用途別：CRM197

  • 用途別：CRM197市場セグメント
    • 肺炎球菌結合型ワクチン
    • 髄膜炎菌多糖類結合型ワクチン
    • その他
  • 用途別：世界のCRM197市場規模（2017、2022、2028）
  • 用途別：世界のCRM197市場規模（2017-2028）
  • 用途別：米国のCRM197市場規模（2017、2022、2028）
  • 用途別：米国のCRM197市場規模（2017-2028）

第4章 企業別：世界のCRM197の競合情勢

  • 企業別：世界のCRM197市場規模
  • 集中率（CR）
  • 本社、製品タイプ
  • 企業のM＆A、拡張計画
  • 企業別：米国のCRM197市場規模

第5章 地域別：世界のCRM197市場規模

  • 地域別：世界のCRM197市場規模（2017 VS 2022 VS 2028）
  • 地域別：世界のCRM197市場規模（2017-2028）

第6章 地域と国レベルのセグメント

  • 北米
    • 市場規模の前年比成長（2017-2028）
    • 国別：市場データ（2017、2022、2028）
    • 米国
    • カナダ
  • アジア太平洋
    • 市場規模の前年比成長（2017-2028）
    • 地域別：市場データ（2017、2022、2028）
    • 中国
    • 日本
    • 韓国
    • インド
  • 欧州
    • 市場規模の前年比成長（2017-2028）
    • 国別：市場データ（2017、2022、2028）
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • ロシア

第7章 主要企業のプロファイル

  • Pfizer Inc.
  • Ligand Pharmaceuticals
  • CanSino Biologic
  • Beijing Kexing Biology Product
  • Scarab Genomics
  • Xpress Biologics
  • Fina Biosolutions
  • Eubiologics
  • EirGenix Inc.

第8章 調査結果と結論

第9章 付録

図表

LIST OF TABLES

  • Table 1. CRM197 Market Size, United States VS Global, CAGR (2017 VS 2022 VS 2028)
  • Table 2. CRM197 Market Trends
  • Table 3. CRM197 Market Drivers
  • Table 4. CRM197 Market Challenges
  • Table 5. CRM197 Market Restraints
  • Table 6. Global CRM197 Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
  • Table 7. United States CRM197 Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
  • Table 8. Global CRM197 Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
  • Table 9. United States CRM197 Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
  • Table 10. Top CRM197 Companies in Global Market, Ranking by Revenue (2021)
  • Table 11. Global CRM197 Revenue by Player, (US$ Million), 2017-2022
  • Table 12. Global CRM197 Revenue Share by Player, 2017-2022
  • Table 13. Global CRM197 Companies Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global CRM197 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRM197 as of 2021)
  • Table 15. Top Players of CRM197 in Global Market, Headquarters and Area Served
  • Table 16. Global CRM197 Companies Product Type
  • Table 17. Date of International Companies Establish
  • Table 18. Companies Mergers & Acquisitions, Expansion Plans
  • Table 19. Top CRM197 Players in United States Market, Ranking by Revenue (2021)
  • Table 20. United States CRM197 Revenue by Players, (US$ Million), 2020, 2021 & 2022
  • Table 21. United States CRM197 Revenue Share by Players, 2020, 2021 & 2022
  • Table 22. Global CRM197 Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
  • Table 23. Global CRM197 Market Size by Region (2017-2022) & (US$ Million)
  • Table 24. Global CRM197 Market Size Forecast by Region (2023-2028) & (US$ Million)
  • Table 25. North America CRM197 Market Size by Country (2017-2022) & (US$ Million)
  • Table 26. North America CRM197 Market Size by Country (2023-2028) & (US$ Million)
  • Table 27. Asia-Pacific CRM197 Market Size by Region (2017-2022) & (US$ Million)
  • Table 28. Asia-Pacific CRM197 Market Size by Region (2023-2028) & (US$ Million)
  • Table 29. Europe CRM197 Market Size by Country (2017-2022) & (US$ Million)
  • Table 30. Europe CRM197 Market Size by Country (2023-2028) & (US$ Million)
  • Table 31. Pfizer Inc. Company Details
  • Table 32. Pfizer Inc. Business Overview
  • Table 33. Pfizer Inc. CRM197 Product
  • Table 34. Pfizer Inc. Revenue in CRM197 Business (2017-2022) & (US$ Million)
  • Table 35. Pfizer Inc. Recent Development
  • Table 36. Ligand Pharmaceuticals Company Details
  • Table 37. Ligand Pharmaceuticals Business Overview
  • Table 38. Ligand Pharmaceuticals CRM197 Product
  • Table 39. Ligand Pharmaceuticals Revenue in CRM197 Business (2017-2022) & (US$ Million)
  • Table 40. Ligand Pharmaceuticals Recent Development
  • Table 41. CanSino Biologic Company Details
  • Table 42. CanSino Biologic Business Overview
  • Table 43. CanSino Biologic CRM197 Product
  • Table 44. CanSino Biologic Revenue in CRM197 Business (2017-2022) & (US$ Million)
  • Table 45. CanSino Biologic Recent Development
  • Table 46. Beijing Kexing Biology Product Company Details
  • Table 47. Beijing Kexing Biology Product Business Overview
  • Table 48. Beijing Kexing Biology Product CRM197 Product
  • Table 49. Beijing Kexing Biology Product Revenue in CRM197 Business (2017-2022) & (US$ Million)
  • Table 50. Scarab Genomics Company Details
  • Table 51. Scarab Genomics Business Overview
  • Table 52. Scarab Genomics CRM197 Product
  • Table 53. Scarab Genomics Revenue in CRM197 Business (2017-2022) & (US$ Million)
  • Table 54. Xpress Biologics Company Details
  • Table 55. Xpress Biologics Business Overview
  • Table 56. Xpress Biologics CRM197 Product
  • Table 57. Xpress Biologics Revenue in CRM197 Business (2017-2022) & (US$ Million)
  • Table 58. Fina Biosolutions Company Details
  • Table 59. Fina Biosolutions Business Overview
  • Table 60. Fina Biosolutions CRM197 Product
  • Table 61. Fina Biosolutions Revenue in CRM197 Business (2017-2022) & (US$ Million)
  • Table 62. Eubiologics Company Details
  • Table 63. Eubiologics Business Overview
  • Table 64. Eubiologics CRM197 Product
  • Table 65. Eubiologics Revenue in CRM197 Business (2017-2022) & (US$ Million)
  • Table 66. Eubiologics Recent Development
  • Table 67. EirGenix Inc. Company Details
  • Table 68. EirGenix Inc. Business Overview
  • Table 69. EirGenix Inc. CRM197 Product
  • Table 70. EirGenix Inc. Revenue in CRM197 Business (2017-2022) & (US$ Million)
  • Table 71. EirGenix Inc. Recent Development
  • Table 72. Research Programs/Design for This Report
  • Table 73. Key Data Information from Secondary Sources
  • Table 74. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global CRM197 Market Size, (US$ Million), 2017 VS 2022 VS 2028
  • Figure 2. Global CRM197 Market Size 2017-2028 (US$ Million)
  • Figure 3. United States CRM197 Market Size, (US$ Million), 2017 VS 2022 VS 2028
  • Figure 4. United States CRM197 Market Size 2017-2028 (US$ Million)
  • Figure 5. United States CRM197 Market Size in Global 2017-2028
  • Figure 6. CRM197 Report Years Considered
  • Figure 7. Global CRM197 Market Share by Type in 2022 & 2028
  • Figure 8. Global CRM197 Market Size by Type (2017-2028) & (US$ Million)
  • Figure 9. Global CRM197 Market Share by Type (2017-2028)
  • Figure 10. United States CRM197 Market Share by Type in 2022 & 2028
  • Figure 11. United States CRM197 Market Size by Type (2017-2028) & (US$ Million)
  • Figure 12. United States CRM197 Market Share by Type (2017-2028)
  • Figure 13. Product Picture of Pneumococcal Conjugate Vaccine
  • Figure 14. Product Picture of Meningococcal Polysaccharide Conjugate Vaccine
  • Figure 15. Product Picture of Others
  • Figure 16. Global CRM197 Market Share by Application in 2022 & 2028
  • Figure 17. Global CRM197 Market Size by Application (2017-2028) & (US$ Million)
  • Figure 18. Global CRM197 Market Share by Application (2017-2028)
  • Figure 19. United States CRM197 Market Share by Application in 2022 & 2028
  • Figure 20. United States CRM197 Market Size by Application (2017-2028) & (US$ Million)
  • Figure 21. United States CRM197 Market Share by Application (2017-2028)
  • Figure 22. The Top 3 Largest Companies of CRM197 in the World: Market Share by CRM197 Revenue in 2021
  • Figure 23. Global CRM197 Market Size Market Share by Region: 2017 VS 2022
  • Figure 24. Global CRM197 Market Share by Region (2017-2028)
  • Figure 25. North America CRM197 Market Size Growth Rate 2017-2028 (US$ Million)
  • Figure 26. United States CRM197 Market Size Growth Rate (2017-2028) & (US$ Million)
  • Figure 27. Canada CRM197 Market Size Growth Rate (2017-2028) & (US$ Million)
  • Figure 28. Asia-Pacific CRM197 Market Size Growth Rate 2017-2028 (US$ Million)
  • Figure 29. China CRM197 Market Size Growth Rate (2017-2028) & (US$ Million)
  • Figure 30. Japan CRM197 Market Size Growth Rate (2017-2028) & (US$ Million)
  • Figure 31. South Korea CRM197 Market Size Growth Rate (2017-2028) & (US$ Million)
  • Figure 32. India CRM197 Market Size Growth Rate (2017-2028) & (US$ Million)
  • Figure 33. Europe CRM197 Market Size Growth Rate 2017-2028 (US$ Million)
  • Figure 34. Germany CRM197 Market Size Growth Rate (2017-2028) & (US$ Million)
  • Figure 35. U.K. CRM197 Market Size Growth Rate (2017-2028) & (US$ Million)
  • Figure 36. France CRM197 Market Size Growth Rate (2017-2028) & (US$ Million)
  • Figure 37. Italy CRM197 Market Size Growth Rate (2017-2028) & (US$ Million)
  • Figure 38. Russia CRM197 Market Size Growth Rate (2017-2028) & (US$ Million)
  • Figure 39. Bottom-up and Top-down Approaches for This Report
  • Figure 40. Data Triangulation
  • Figure 41. Key Executives Interviewed
目次

Market Analysis and Insights:

This report focuses on global and United States CRM197 market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global CRM197 market size is estimated to be worth US$ 177.06 million in 2022 and is forecast to a readjusted size of US$ 240.83 million by 2028 with a CAGR of 5.26% during the review period. Fully considering the economic change by this health crisis, Research Grade accounting for 12.18% of the CRM197 global market in 2021, is projected to value US$ 29.13 million by 2028, growing at a revised 5.16% CAGR in the post-COVID-19 period. While Pneumococcal Conjugate Vaccine was the leading segment, accounting for over 89.19 percent market share in 2021, and altered to an 5.29 % CAGR throughout this forecast period.

In United States the CRM197 market size is expected to grow from US$ 124.12 million in 2021 to US$ 175.23 million by 2028, at a CAGR of 5.58% during the forecast period.

Scope and Market Size:

CRM197 market is segmented in regional and country level, by players, by Type, and by Application. Players, stakeholders, and other participants in the global CRM197 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the CRM197 market size by players, by Type, and by Application, for the period 2017-2028. The key players include the global and local players which play important roles in United States.

By Company

  • Pfizer Inc.
  • Fina Biosolutions
  • Eubiologics
  • EirGenix Inc.
  • Xpress Biologics
  • Ligand Pharmaceuticals
  • Scarab Genomics
  • CanSino Biologic
  • Beijing Kexing Biology Product

Segment by Type

  • Research Grade
  • CGMP Grade

Segment by Application

  • Pneumococcal Conjugate Vaccine
  • Meningococcal Polysaccharide Conjugate Vaccine
  • Others

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia

TABLE OF CONTENTS

1 STUDY COVERAGE

  • 1.1 CRM197 Product Introduction
  • 1.2 Global CRM197 Outlook, 2017 VS 2022 VS 2028
    • 1.2.1 Global CRM197 Market Size for the Year 2017-2028
    • 1.2.2 United States CRM197 Market Size for the Year 2017-2028
  • 1.3 CRM197 Market Size, United States VS Global, 2017 VS 2022 VS 2028
    • 1.3.1 The Market Size of United States CRM197 in Global, 2017 VS 2022 VS 2028
    • 1.3.2 The Growth Rate of CRM197 Market Size, United States VS Global, 2017 VS 2022 VS 2028
  • 1.4 CRM197 Market Dynamics
    • 1.4.1 CRM197 Industry Trends
    • 1.4.2 CRM197 Market Drivers
    • 1.4.3 CRM197 Market Challenges
    • 1.4.4 CRM197 Market Restraints
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 CRM197 BY TYPE

  • 2.1 CRM197 Market Segment by Type
    • 2.1.1 Research Grade
    • 2.1.2 CGMP Grade
  • 2.2 Global CRM197 Market Size by Type (2017, 2022 & 2028)
  • 2.3 Global CRM197 Market Size by Type (2017-2028)
  • 2.4 United States CRM197 Market Size by Type (2017, 2022 & 2028)
  • 2.5 United States CRM197 Market Size by Type (2017-2028)

3 CRM197 BY APPLICATION

  • 3.1 CRM197 Market Segment by Application
    • 3.1.1 Pneumococcal Conjugate Vaccine
    • 3.1.2 Meningococcal Polysaccharide Conjugate Vaccine
    • 3.1.3 Others
  • 3.2 Global CRM197 Market Size, by Application (2017, 2022 & 2028)
  • 3.3 Global CRM197 Market Size by Application (2017-2028)
  • 3.4 United States CRM197 Market Size by Application (2017, 2022 & 2028)
  • 3.5 United States CRM197 Market Size by Application (2017-2028)

4 GLOBAL CRM197 COMPETITOR LANDSCAPE BY COMPANY

  • 4.1 Global CRM197 Market Size by Company
    • 4.1.1 Top Global CRM197 Companies Ranked by Revenue (2021)
    • 4.1.2 Global CRM197 Revenue by Player (2017-2022)
  • 4.2 Global CRM197 Concentration Ratio (CR)
    • 4.2.1 CRM197 Market Concentration Ratio (CR) (2017-2022)
    • 4.2.2 Global Top 3 Largest Companies of CRM197 in 2021
    • 4.2.3 Global CRM197 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 4.3 Global CRM197 Headquarters, Product Type
    • 4.3.1 Global CRM197 Headquarters and Area Served
    • 4.3.2 Global CRM197 Companies Product Type
    • 4.3.3 Date of International Companies Establish
  • 4.4 Companies Mergers & Acquisitions, Expansion Plans
  • 4.5 United States CRM197 Market Size by Company
    • 4.5.1 Top CRM197 Players in United States, Ranked by Revenue (2021)
    • 4.5.2 United States CRM197 Revenue by Players (2020, 2021 & 2022)

5 GLOBAL CRM197 MARKET SIZE BY REGION

  • 5.1 Global CRM197 Market Size by Region: 2017 VS 2022 VS 2028
  • 5.2 Global CRM197 Market Size by Region (2017-2028)
    • 5.2.1 Global CRM197 Market Size by Region: 2017-2022
    • 5.2.2 Global CRM197 Market Size by Region: 2023-2028

6 SEGMENT IN REGIONAL LEVEL & COUNTRY LEVEL

  • 6.1 North America
    • 6.1.1 North America CRM197 Market Size YoY Growth 2017-2028
    • 6.1.2 North America CRM197 Market Facts & Figures by Country (2017, 2022 & 2028)
    • 6.1.3 United States
    • 6.1.4 Canada
  • 6.2 Asia-Pacific
    • 6.2.1 Asia-Pacific CRM197 Market Size YoY Growth 2017-2028
    • 6.2.2 Asia-Pacific CRM197 Market Facts & Figures by Region (2017, 2022 & 2028)
    • 6.2.3 China
    • 6.2.4 Japan
    • 6.2.5 South Korea
    • 6.2.6 India
  • 6.3 Europe
    • 6.3.1 Europe CRM197 Market Size YoY Growth 2017-2028
    • 6.3.2 Europe CRM197 Market Facts & Figures by Country (2017, 2022 & 2028)
    • 6.3.3 Germany
    • 6.3.4 U.K.
    • 6.3.5 France
    • 6.3.6 Italy
    • 6.3.7 Russia

7 KEY PLAYERS PROFILES

  • 7.1 Pfizer Inc.
    • 7.1.1 Pfizer Inc. Company Details
    • 7.1.2 Pfizer Inc. Business Overview
    • 7.1.3 Pfizer Inc. CRM197 Introduction
    • 7.1.4 Pfizer Inc. Revenue in CRM197 Business (2017-2022)
    • 7.1.5 Pfizer Inc. Recent Development
  • 7.2 Ligand Pharmaceuticals
    • 7.2.1 Ligand Pharmaceuticals Company Details
    • 7.2.2 Ligand Pharmaceuticals Business Overview
    • 7.2.3 Ligand Pharmaceuticals CRM197 Introduction
    • 7.2.4 Ligand Pharmaceuticals Revenue in CRM197 Business (2017-2022)
    • 7.2.5 Ligand Pharmaceuticals Recent Development
  • 7.3 CanSino Biologic
    • 7.3.1 CanSino Biologic Company Details
    • 7.3.2 CanSino Biologic Business Overview
    • 7.3.3 CanSino Biologic CRM197 Introduction
    • 7.3.4 CanSino Biologic Revenue in CRM197 Business (2017-2022)
    • 7.3.5 CanSino Biologic Recent Development
  • 7.4 Beijing Kexing Biology Product
    • 7.4.1 Beijing Kexing Biology Product Company Details
    • 7.4.2 Beijing Kexing Biology Product Business Overview
    • 7.4.3 Beijing Kexing Biology Product CRM197 Introduction
    • 7.4.4 Beijing Kexing Biology Product Revenue in CRM197 Business (2017-2022)
  • 7.5 Scarab Genomics
    • 7.5.1 Scarab Genomics Company Details
    • 7.5.2 Scarab Genomics Business Overview
    • 7.5.3 Scarab Genomics CRM197 Introduction
    • 7.5.4 Scarab Genomics Revenue in CRM197 Business (2017-2022)
  • 7.6 Xpress Biologics
    • 7.6.1 Xpress Biologics Company Details
    • 7.6.2 Xpress Biologics Business Overview
    • 7.6.3 Xpress Biologics CRM197 Introduction
    • 7.6.4 Xpress Biologics Revenue in CRM197 Business (2017-2022)
  • 7.7 Fina Biosolutions
    • 7.7.1 Fina Biosolutions Company Details
    • 7.7.2 Fina Biosolutions Business Overview
    • 7.7.3 Fina Biosolutions CRM197 Introduction
    • 7.7.4 Fina Biosolutions Revenue in CRM197 Business (2017-2022)
  • 7.8 Eubiologics
    • 7.8.1 Eubiologics Company Details
    • 7.8.2 Eubiologics Business Overview
    • 7.8.3 Eubiologics CRM197 Introduction
    • 7.8.4 Eubiologics Revenue in CRM197 Business (2017-2022)
    • 7.8.5 Eubiologics Recent Development
  • 7.9 EirGenix Inc.
    • 7.9.1 EirGenix Inc. Company Details
    • 7.9.2 EirGenix Inc. Business Overview
    • 7.9.3 EirGenix Inc. CRM197 Introduction
    • 7.9.4 EirGenix Inc. Revenue in CRM197 Business (2017-2022)
    • 7.9.5 EirGenix Inc. Recent Development

8 RESEARCH FINDINGS AND CONCLUSION

9 APPENDIX

  • 9.1 Research Methodology
    • 9.1.1 Methodology/Research Approach
    • 9.1.2 Data Source
  • 9.2 Disclaimer
  • 9.3 Author Details